Barbara Gayle Duncan Insider Trading $ICPT INTERCEPT PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Barbara Gayle Duncan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Barbara Gayle Duncan. Barbara Gayle Duncan is Chief Financial Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT).
Barbara Gayle Duncan in INTERCEPT PHARMACEUTICALS, INC.
Trading Symbol: ICPTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Barbara Gayle Duncan: Chief Financial Officer
Holdings: 17,264 shares
Current Value: $1,960,672
Latest Transaction: Jan 07 2015
$ICPT Market Capitalization: $2.80B
$ICPT Previous Close: $113.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Barbara Gayle Duncan in INTERCEPT PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 07 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 176.49 | 141 | 24,884 | 17,264 | 17.4 K to 17.3 K (-0.81 %) |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 31.90 | 1,000 | 31,900 | 14,875 | |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,298 | 0 | 5,192 | |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 158.35 | 500 | 79,175 | 17,405 | 17.9 K to 17.4 K (-2.79 %) |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 154.45 | 500 | 77,225 | 17,905 | 18.4 K to 17.9 K (-2.72 %) |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 31.90 | 1,000 | 31,900 | 18,405 | 17.4 K to 18.4 K (+5.75 %) |
Jan 05 2015 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 0.00 | 1,298 | 0 | 17,405 | 16.1 K to 17.4 K (+8.06 %) |
Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 31.90 | 1,000 | 31,900 | 15,875 | |
Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,299 | 0 | 6,490 | |
Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 234.87 | 100 | 23,487 | 16,107 | 16.2 K to 16.1 K (-0.62 %) |
Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 232.92 | 900 | 209,632 | 16,207 | 17.1 K to 16.2 K (-5.26 %) |
Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 31.90 | 1,000 | 31,900 | 17,107 | 16.1 K to 17.1 K (+6.21 %) |
Oct 03 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 0.00 | 1,299 | 0 | 16,107 | 14.8 K to 16.1 K (+8.77 %) |
Apr 15 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 21.50 | 1,154 | 24,811 | 8,365 | |
Apr 15 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | A | 266.01 | 6,650 | 1,768,967 | 6,650 | |
Apr 15 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | A | 266.01 | 1,835 | 488,128 | 1,835 | |
Apr 15 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Sell | S | 279.00 | 1,154 | 321,966 | 13,510 | 14.7 K to 13.5 K (-7.87 %) |
Apr 15 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 21.50 | 1,154 | 24,811 | 14,664 | 13.5 K to 14.7 K (+8.54 %) |
Apr 15 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Grant | A | 0.00 | 1,504 | 0 | 13,510 | 12 K to 13.5 K (+12.53 %) |
Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,298 | 0 | 9,087 | |
Apr 03 2014 | ICPT | INTERCEPT PHARMACE ... | Duncan Barbara Gayle | Chief Financial Off ... | Buy | M | 0.00 | 1,298 | 0 | 12,006 | 10.7 K to 12 K (+12.12 %) |
Page: 1